<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE
ACT OF 1934
Date of Report (Date of earliest event reported):
Not Applicable
NATIONAL HEALTH INVESTORS, INC.
(Exact name of registrant as specified in its charter)
Maryland 001-10822 62-1470956
-------- --------- ---------------
(State or other (Commission (I.R.S. Employer
jurisdiction of File Number) Identification
incorporation) Number)
100 Vine Street, Suite 1400, City Center, Murfreesboro, Tennessee 37130
------------------------------------------------------------------------
(Address of principal executive offices)
(615) 890-9100
--------------------------------------------------
(Registrant's telephone number, including area code)
Not Applicable
--------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report)
---------------------------------------------------------------------
Exhibit Index on Page 3
<PAGE> 2
ITEM 5. OTHER EVENTS.
Attached as an exhibit hereto is the First Supplemental Indenture
between the registrant and U.S. Bank relating to the offering of up to
$20,000,000 principal amount of Prime plus 1% Debentures due 2006.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
NATIONAL HEALTH INVESTORS, INC.
By: /s/ Richard F. LaRoche, Jr.
---------------------------
Name: Richard F. LaRoche, Jr.
Title: Vice President
Date: December 7, 2000
<PAGE> 3
Exhibit Index
<TABLE>
<CAPTION>
Exhibit No.
-----------
<S> <C>
4.1 First Supplemental Indenture between National Health
Investors, Inc. and U.S. Bank.
</TABLE>
